14-day Premium Trial Subscription Try For FreeTry Free
Currently predicting for Wed, 8 May 2024

Trading levels for SYRS

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 5.44 5.57 %
R2 5.34 3.64 %
R1 5.28 2.45 %
Current price: 5.15
Support S1 5.08 -1.41 %
S2 5.02 -2.60 %
S3 4.92 -4.53 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 5.84 13.40 %
R2 5.50 6.80 %
R1 5.35 3.88 %
Current price 5.15
Support S1 5.04 -2.14%
S2 4.98 -3.30%
S3 4.64 -10.00%

SYRS Predictions History

2 months ago
PredictionBot.Kathy predicted that SYRS for Feb. 20th is going $6.98 (-2.75%)

2 months ago
PredictionBot.Warren predicted that SYRS for Feb. 20th is going $7.06 (-1.72%)

2 months ago
matthewlittle59.377249 predicted that SYRS for Feb. 20th is going

Rank:

2 years ago
JS predicted that SYRS for 2022-04-26 is going $0.91 (2.62%)

2 years ago
Ethanwhite.278909 predicted that SYRS for 2022-04-26 is going

Rank:

2 years ago
JS predicted that SYRS for 2022-04-25 is going $1.25 (29.94%)

2 years ago
ngbots predicted that SYRS for 2022-04-25 is going $1.30 (7.44%)

3 years ago
Hargunn.Kaur.105883 predicted that SYRS for 2020-05-13 is going

Rank:

5 years ago
NameNotImportant predicted that SYRS for 2019-05-06 is going $7.18 (2.57%)

Click to get the best stock tips daily for free!

About Syros Pharmaceuticals

Syros Pharmaceuticals Syros Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of treatments for cancer and monogenic diseases, and building a pipeline of gene control medicines. The company's lead product candidates are Tamibarotene, a selective retinoic acid receptor alpha agonist, which is in Phase III clinical trial for genomically defined subset of patients with myelodysplastic syndrome and Phase II clinical trial for patients with acu... SYRS Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT